UConn Health

Leaky Blood Vessels. Two conceptual images of a cancer tumor blood vessel. In (A), the right side of the blood vessel (marked by the dark gray bar below the pore) is leaky, with a large pore that allows too much fluid to leave the vessel. The left side shows the same blood vessel after dexamethasone treatment; the pore is smaller and the vessel less leaky. Dexamethasone treatment does the same thing to the vessel pores in (B). The smaller pores allow more anti-cancer drug (green dots) to travel further inside the tumor, leading to more effective treatment. (John Martin, University of Tokyo, and Matthew Stuber, UConn)

Common Steroid Could Soften Up Tumors for Chemo

A drug used to alleviate side effects of cancer treatment may also make the treatment more successful if given beforehand, researchers say.

Dr. Jennifer Ozimek stands in front of the tower at UConn Health.

Meet Dr. Jennifer Ozimek, Primary Care Physician

Practicing medicine at UConn Health is a dream come true for Dr. Ozimek. She set her sights on UConn while attending a clinical career day here in high school.

Pharmacists and customers. (Getty Images)

Study: More Pharma Money, More Gabapentin

Gabapentin manufacturers paid physicians – mostly pain doctors and general practitioners – $11.5 million between 2014 and 2016, according to UConn research.

UConn wordmark.

UConn Adopts New FY20 Budget

The budgets, which go into effect July 1, include $1.46 billion for Storrs and the regional campuses, and $1.24 billion for UConn Health, including the UConn John Dempsey Hospital and the schools of medicine and dental medicine.

Bone marrow stem cells. (Getty Images)

Tapping into the Way Cells Communicate

For the first time, scientists can record cells communicating in real time, opening the floodgates for new developments in cell therapy and other areas within cell biology.

A blood vessel blocked by red blood cells that are affected by sickle cell anemia and are crescent shaped. (Getty Images)

Sickle Cell Drug Showing Promise in Clinical Trial

In early clinical trial data, the experimental drug has shown promise for impacting important biological markers in the red and white blood cells of sickle cell patients.

Four researchers listening to/watching Victor Hesselbrock at a chalk board.

UConn’s Alcohol Research Center Continues Unprecedented Run

With its latest five-year, $7.5 million award from the National Institutes of Health, UConn Health's Alcohol Research Center remains the longest funded in the nation.

UConn wordmark.

UConn Crafting New FY20 Budget with Focus on Protecting Academic, Research Strength

The Financial Affairs Committee voted Tuesday to send the proposed budgets to the full Board of Trustees, which will consider them at the June 26 meeting.

A doctor giving a baby an injection. (Getty Images)

The Ongoing Debate About Vaccines

Vaccines are important not only for personal health, but to protect other vulnerable people, says UConn Health pediatrician Dr. Jody Terranova.

Dr. Jillian Fortier, plastic and reconstructive surgeon at UConn Health, with a young patient she helped during a mission trip abroad. (Ethan Giorgetti/UConn Health Photo)

Meet Dr. Jillian Fortier, Plastic and Reconstructive Surgeon

At home and abroad, UConn Health's Dr. Jillian Fortier combines compassion for her patients with top-notch skills.